A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

Source:http://linkedlifedata.com/resource/pubmed/id/17698191

Download in:

View as

General Info

PMID
17698191